{"meta":{"query_hash":"68fff1edfae6","filters":{"venue":"Clinical Research (Excluding Clinical Trials)"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/68fff1edfae6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Research+%28Excluding+Clinical+Trials%29"},"results":[{"id":"W2953914066","doi":"10.1158/1538-7445.sabcs18-463","title":"Abstract 463: Integrated digital pathology and transcriptome analysis identifies molecular mediators of T cell exclusion in ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ovarian cancer; Transcriptome; CD8; Cytotoxic T cell; Immunotherapy; Biology; Phenotype; Cancer research; Cancer; Ovarian carcinoma; Immune system; Pathology; Medicine; Immunology; Gene expression; In vitro; Gene; Genetics","score_opus":0.2873265918370317,"score_gpt":0.5490763127051037,"score_spread":0.261749720868072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953914066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935376,0.0021508636,0.00009009737,0.0013159673,0.0009971065,0.001171375,0.00010653842,0.000028835713,0.00060161913],"genre_scores_gemma":[0.9865563,0.012323165,0.0001123149,0.00022406565,0.00026403426,0.00003604496,0.00006223102,0.00003791709,0.0003839176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890527,0.0032422969,0.004841731,0.0010946385,0.0010840064,0.0006845909],"domain_scores_gemma":[0.97715884,0.020322153,0.00071788335,0.0007659873,0.00052472664,0.00051038555],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05107089,0.00028654246,0.0028558604,0.0009922879,0.00007084621,0.000084940104,0.00038545465,0.0008349984,0.001369715],"category_scores_gemma":[0.029508745,0.00021553328,0.0015533618,0.0022244367,0.0012113554,0.00018892446,0.00021468067,0.0020059487,0.00004922369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020267654,0.0017991078,0.7006542,0.00038075572,0.0021614882,0.00038928507,0.00025409562,0.000009608146,0.21040308,0.00004796039,0.0005205004,0.06311226],"study_design_scores_gemma":[0.027163817,0.0025524863,0.95137566,0.0011322593,0.0010182591,0.0000070819424,0.0008474699,0.0005393306,0.010223035,0.0009628514,0.0036795987,0.00049814075],"about_ca_topic_score_codex":0.00040702528,"about_ca_topic_score_gemma":0.00012490952,"teacher_disagreement_score":0.25072145,"about_ca_system_score_codex":0.00012100561,"about_ca_system_score_gemma":0.00069768965,"threshold_uncertainty_score":0.9995432},"labels":[],"label_agreement":null},{"id":"W2954662627","doi":"10.1158/1538-7445.sabcs18-3134","title":"Abstract 3134: CCN3 is a prognostic biomarker and functional mediator of prostate cancer bone metastasis","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Prostate cancer; Mediator; Bone metastasis; Medicine; Metastasis; Oncology; Biomarker; Internal medicine; Cancer research; Cancer; Biology","score_opus":0.5839358741185923,"score_gpt":0.5988919893140373,"score_spread":0.014956115195445041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954662627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002177,0.004180528,0.000027918264,0.0020722854,0.00091656984,0.002049287,0.00032309582,0.000020702108,0.00038783095],"genre_scores_gemma":[0.9894752,0.007563364,0.00017017304,0.00015276244,0.0011404149,0.00018909227,0.000071945244,0.00006570232,0.0011713644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98756903,0.0051257135,0.0032337874,0.0016041914,0.0014941853,0.00097307225],"domain_scores_gemma":[0.97202814,0.024161367,0.0006759411,0.00090549875,0.0014111683,0.0008179012],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.063533396,0.00032749237,0.0015563519,0.0002764849,0.0001600807,0.00008829986,0.00046365082,0.0006809944,0.0016587892],"category_scores_gemma":[0.1607022,0.000264017,0.0008241005,0.00057492225,0.0014124279,0.000024203287,0.0010376769,0.001448418,0.00021894962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005838403,0.0008543299,0.7780885,0.00030454068,0.001182012,0.000019299785,0.000031378248,0.0000014634217,0.091255605,0.000093397925,0.01718989,0.10514115],"study_design_scores_gemma":[0.009318749,0.0030063933,0.88745385,0.0003460188,0.00017050108,0.000006490091,0.00016948432,0.00016913441,0.022625238,0.0010339989,0.07512384,0.00057629996],"about_ca_topic_score_codex":0.00008910611,"about_ca_topic_score_gemma":0.00003884517,"teacher_disagreement_score":0.10936532,"about_ca_system_score_codex":0.00004543555,"about_ca_system_score_gemma":0.0010995998,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2954855872","doi":"10.1158/1538-7445.sabcs18-2272","title":"Abstract 2272: Exploratory analysis of T cell repertoire dynamics upon systemic treatment with the oncolytic virus pelareorep in combination with pembrolizumab and chemotherapy in patients with advanced pancreatic adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Pembrolizumab; Oncolytic virus; Gemcitabine; Medicine; Chemotherapy; CD8; Irinotecan; Cancer research; Oncology; Immunotherapy; Internal medicine; Immune system; Immunology; Cancer; Colorectal cancer","score_opus":0.12511971667123817,"score_gpt":0.4509382467694909,"score_spread":0.32581853009825273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954855872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609214,0.00071619917,0.000027932736,0.0002449147,0.000044160948,0.0027477378,0.00003950873,0.0000103837465,0.000076998454],"genre_scores_gemma":[0.9963108,0.0030080401,0.00007076818,0.000060316223,0.00006569392,0.00018760323,0.00013586655,0.00006612902,0.000094785944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9905047,0.0046335435,0.0019742115,0.0011944885,0.0010424516,0.000650609],"domain_scores_gemma":[0.99047834,0.0066856532,0.0007398817,0.0012542574,0.0005765286,0.00026535665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017870227,0.0003556458,0.0017514024,0.00046039067,0.00010684819,0.00005763909,0.0004981085,0.00040666707,0.000028799612],"category_scores_gemma":[0.0024358043,0.00020507013,0.00030880203,0.0013451668,0.0006540203,0.000028606468,0.00013403699,0.0009004286,0.0000063998723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.094400175,0.0022442075,0.8819119,0.00010292316,0.0010669882,0.00001893682,0.00013140081,0.00061734754,0.002965492,0.00000952761,0.000009309087,0.016521834],"study_design_scores_gemma":[0.048656795,0.07191453,0.8703823,0.0005076645,0.00037693235,0.0000016316724,0.00093645114,0.0038633684,0.0028266525,0.000027254597,0.000052059477,0.0004543492],"about_ca_topic_score_codex":0.00010102439,"about_ca_topic_score_gemma":0.0027646867,"teacher_disagreement_score":0.06967032,"about_ca_system_score_codex":0.00032117125,"about_ca_system_score_gemma":0.0008252879,"threshold_uncertainty_score":0.83625174},"labels":[],"label_agreement":null},{"id":"W2955358464","doi":"10.1158/1538-7445.sabcs18-4912","title":"Abstract 4912: A snapshot of myeloproliferative neoplasms in the United States: Analysis of the “myMPN” patient registry","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Snapshot (computer storage); Computer science; Medicine; Database","score_opus":0.5550935003392555,"score_gpt":0.5987014889231944,"score_spread":0.043607988583938884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955358464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98696494,0.00027936895,0.0000071182094,0.00678093,0.00050807,0.003509905,0.00017396844,0.000014234865,0.0017614447],"genre_scores_gemma":[0.9942469,0.00354295,0.00015812505,0.0011659858,0.00027632545,0.0001878093,0.00023786908,0.000032127373,0.00015188692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9747024,0.013619005,0.007120422,0.0011325276,0.0026083153,0.00081733783],"domain_scores_gemma":[0.8132452,0.17833537,0.0027841614,0.002949376,0.0020965536,0.0005893744],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06602666,0.0003976025,0.003735742,0.000802926,0.00017876743,0.00006428939,0.00093552144,0.0006116282,0.0009937623],"category_scores_gemma":[0.13632734,0.00019732436,0.0025380396,0.005114882,0.0014960276,0.00008795051,0.0004265817,0.0029565392,0.000057335135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047731968,0.0052227476,0.97209835,0.00016691211,0.0042502484,0.000050020884,0.001068686,0.0004969952,0.00010733686,0.0017892332,0.0044674263,0.0055088694],"study_design_scores_gemma":[0.008298701,0.0042400276,0.9709704,0.0010496309,0.0015071296,0.0000031455784,0.0022747107,0.0034496055,0.00090321235,0.001038174,0.0060258047,0.00023948753],"about_ca_topic_score_codex":0.0004955866,"about_ca_topic_score_gemma":0.00026343693,"teacher_disagreement_score":0.16471636,"about_ca_system_score_codex":0.00015997149,"about_ca_system_score_gemma":0.0010492472,"threshold_uncertainty_score":0.9999195},"labels":[],"label_agreement":null},{"id":"W2955594557","doi":"10.1158/1538-7445.sabcs18-4915","title":"Abstract 4915: Optimal frequency of follow up scans on systemictherapy for advanced malignancies","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Nuclear medicine; Regimen; Progression-free survival; Confidence interval; Surgery; Internal medicine; Overall survival","score_opus":0.4580237976289348,"score_gpt":0.5750532241862021,"score_spread":0.11702942655726728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955594557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902838,0.0016076398,0.0005038602,0.00042016205,0.0032614383,0.0022227939,0.00035613187,0.000019324018,0.0013248879],"genre_scores_gemma":[0.9872547,0.0068063387,0.0019405602,0.0003122868,0.002361051,0.00016660633,0.000109284294,0.000076088814,0.0009731153],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99227446,0.0015530564,0.003538228,0.0011828508,0.00064346654,0.00080795714],"domain_scores_gemma":[0.969823,0.026693685,0.00086913235,0.0011907439,0.0009804093,0.00044304837],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03831306,0.00030123343,0.0015717902,0.00012872647,0.00014530602,0.000064084124,0.0008437793,0.0007931826,0.00010080335],"category_scores_gemma":[0.101192854,0.00025662102,0.0015225306,0.00022382801,0.00050069875,0.000010396123,0.00025822804,0.00078800425,0.00009242109],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028626679,0.0025303485,0.10402089,0.00076990755,0.0017199934,0.000015171746,0.000089677684,0.0010610658,0.69057065,0.010889187,0.03160115,0.12810525],"study_design_scores_gemma":[0.11262827,0.074536905,0.086831845,0.005374162,0.00057258765,0.00001370228,0.0021784601,0.0019158507,0.24412201,0.022820618,0.4446895,0.004316073],"about_ca_topic_score_codex":0.000036036192,"about_ca_topic_score_gemma":0.000028707018,"teacher_disagreement_score":0.44644865,"about_ca_system_score_codex":0.000059816244,"about_ca_system_score_gemma":0.0008934355,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W4251150431","doi":"10.1158/1538-7445.sabcs18-3106","title":"Abstract 3106: Targeting vitamin D signalling in metastatic neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Calcipotriol; Calcitriol receptor; Cancer research; Medicine; Cancer; Metastasis; Internal medicine; In vivo; Neuroblastoma; Vitamin D and neurology; Cell culture; Oncology; Endocrinology; Biology; Immunology; Genetics","score_opus":0.6529813063708557,"score_gpt":0.6331836510641294,"score_spread":0.01979765530672628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251150431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884672,0.0003063499,0.000046036104,0.0025865843,0.0012337272,0.0035998577,0.000024601713,0.00015572805,0.0035798696],"genre_scores_gemma":[0.99284613,0.0018346307,0.0013866902,0.0005320849,0.0013873244,0.00011865763,0.000042601518,0.00014312056,0.0017087591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9701685,0.014388193,0.0075960984,0.0023051514,0.0030933365,0.0024487546],"domain_scores_gemma":[0.8221467,0.17144246,0.0010610311,0.0016071034,0.0010591618,0.002683536],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.13304181,0.00054518273,0.0036357217,0.0009892521,0.00024952058,0.0002090403,0.00082101516,0.0005650259,0.0017080442],"category_scores_gemma":[0.28238386,0.0004255823,0.001792612,0.0017542804,0.0008530395,0.00035227492,0.0007381177,0.0069083944,0.005664386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034420475,0.018508403,0.6502295,0.0015911272,0.0022829175,0.011456307,0.00012853909,0.00017530684,0.054456886,0.0008031996,0.021641457,0.20430586],"study_design_scores_gemma":[0.08187957,0.02487788,0.83689857,0.0049757347,0.000496071,0.00010060662,0.0006871968,0.009954721,0.006406545,0.005951955,0.026072875,0.0016982617],"about_ca_topic_score_codex":0.00008080942,"about_ca_topic_score_gemma":0.000027398684,"teacher_disagreement_score":0.20260759,"about_ca_system_score_codex":0.0002582658,"about_ca_system_score_gemma":0.0014145704,"threshold_uncertainty_score":0.9998196},"labels":[],"label_agreement":null},{"id":"W4253579964","doi":"10.1158/1538-7445.sabcs18-3123","title":"Abstract 3123: Targeting SHP2 and RAS MAPK pathway in neuroblastoma","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Cancer research; MAPK/ERK pathway; Neuroblastoma; PTPN11; Biology; Cell growth; Signal transduction; Protein tyrosine phosphatase; Apoptosis; Effector; Cell culture; Mutation; Immunology; Cell biology; Genetics; Gene; KRAS","score_opus":0.5040751012027124,"score_gpt":0.60227938327089,"score_spread":0.09820428206817766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253579964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315804,0.0010510712,0.00004766516,0.0010548804,0.00086822856,0.0011494866,0.000033492983,0.00003046282,0.0026066478],"genre_scores_gemma":[0.99061084,0.0048070704,0.00029360043,0.000366062,0.0024639675,0.000049174654,0.000059082457,0.000075684264,0.0012745118],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98397386,0.008087632,0.0036794979,0.0018201469,0.0010599856,0.0013788942],"domain_scores_gemma":[0.9703606,0.026860168,0.00043887226,0.00103989,0.00040702696,0.00089348125],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09171539,0.0003391991,0.0014061932,0.0002465133,0.00020789284,0.00017068187,0.0008242335,0.00097536755,0.00041454728],"category_scores_gemma":[0.17674577,0.0002844428,0.00073246006,0.00048956793,0.0008805056,0.000025332105,0.0013969681,0.0028318597,0.0006153524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067763194,0.002016131,0.39480853,0.00030814589,0.00036224342,0.00035380945,0.00003814469,0.000038125723,0.3831449,0.0004982086,0.02745855,0.1841969],"study_design_scores_gemma":[0.025701523,0.010633291,0.3836368,0.0012182154,0.000051078143,0.000014845301,0.0008013596,0.0020682362,0.059620496,0.0034922373,0.51061535,0.0021465726],"about_ca_topic_score_codex":0.00005311962,"about_ca_topic_score_gemma":0.000040514347,"teacher_disagreement_score":0.4831568,"about_ca_system_score_codex":0.000034247143,"about_ca_system_score_gemma":0.00063327985,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W4254205573","doi":"10.1158/1538-7445.sabcs18-1375","title":"Abstract 1375: Multiplex gene expression using the HyCEAD assay in CTCs isolated with the Parsortix™ system","year":2019,"lang":"en","type":"article","venue":"Clinical Research (Excluding Clinical Trials)","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aptose Biosciences (Canada)","funders":"","keywords":"Multiplex; Gene; Computational biology; Biology; Computer science; Genetics","score_opus":0.7077130721999437,"score_gpt":0.6386006527521464,"score_spread":0.06911241944779734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254205573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683156,0.00025020313,0.0055059027,0.019195216,0.0005034958,0.004976583,0.00001640377,0.00025332838,0.0009832858],"genre_scores_gemma":[0.99061525,0.000577903,0.0057577486,0.00081287004,0.0015330383,0.00021357408,0.000021187057,0.00007605179,0.00039238718],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98291343,0.008666891,0.004233716,0.0012216071,0.0019028086,0.001061572],"domain_scores_gemma":[0.88137466,0.11220678,0.0013178866,0.003110155,0.00093324884,0.0010573027],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.13587277,0.00033598402,0.0018363026,0.00017876588,0.00044666696,0.0001474179,0.0010850264,0.00070090324,0.0002306185],"category_scores_gemma":[0.07317832,0.00015368818,0.0007197155,0.0011399218,0.0013856321,0.00011919744,0.00056504586,0.005521382,0.00025124557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018988624,0.00704859,0.63763326,0.0012123993,0.001235909,0.00073517725,0.00039745716,0.00029129037,0.14734036,0.003540567,0.08843998,0.09313637],"study_design_scores_gemma":[0.05018252,0.006710829,0.28249344,0.01956898,0.0011995926,0.0002722259,0.004125008,0.42580742,0.010988697,0.0017533535,0.19461441,0.002283523],"about_ca_topic_score_codex":0.0001851078,"about_ca_topic_score_gemma":0.000017192451,"teacher_disagreement_score":0.42551613,"about_ca_system_score_codex":0.00024063345,"about_ca_system_score_gemma":0.00070719223,"threshold_uncertainty_score":0.99677294},"labels":[],"label_agreement":null}]}